Next Article in Journal
Recent Advances in Aptamer-Based Sensors for Sensitive Detection of Neurotransmitters
Previous Article in Journal
Gold Nanoparticle-Based Plasmonic Biosensors
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biosensors
Volume 13
Issue 3
10.3390/bios13030412
biosensors-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Perspective

A Short Review on Miniaturized Biosensors for the Detection of Nucleic Acid Biomarkers

by
Madhusudan B. Kulkarni
1,2,
Narasimha H. Ayachit
3 and
Tejraj M. Aminabhavi
3,*
1
School of Electronics and Communication Engineering, KLE Technological University, Vidyanagar, Hubballi 580023, Karnataka, India
2
Medical Physics Department, Wisconsin Institutes for Medical Research, University of Wisconsin, Madison, WI 53705, USA
3
School of Advanced Sciences, KLE Technological University, Hubballi 580031, Karnataka, India
*
Author to whom correspondence should be addressed.
Biosensors 2023, 13(3), 412; https://doi.org/10.3390/bios13030412
Submission received: 20 February 2023 / Revised: 17 March 2023 / Accepted: 20 March 2023 / Published: 22 March 2023
(This article belongs to the Special Issue Biosensors for Nucleic Acid Biomarkers)
Browse Figures
Versions Notes

Abstract

:
Even today, most biomarker testing is executed in centralized, dedicated laboratories using bulky instruments, automated analyzers, and increased analysis time and expenses. The development of miniaturized, faster, low-cost microdevices is immensely anticipated for substituting for these conventional laboratory-oriented assays and transferring diagnostic results directly onto the patient’s smartphone using a cloud server. Pioneering biosensor-based approaches might make it possible to test biomarkers with reliability in a decentralized setting, but there are still a number of issues and restrictions that must be resolved before the development and use of several biosensors for the proper understanding of the measured biomarkers of numerous bioanalytes such as DNA, RNA, urine, and blood. One of the most promising processes to address some of the issues relating to the growing demand for susceptible, quick, and affordable analysis techniques in medical diagnostics is the creation of biosensors. This article critically discusses a short review of biosensors used for detecting nucleic acid biomarkers, and their use in biomedical prognostics will be addressed while considering several essential characteristics.

1. Introduction

Biosensing techniques have become one of the hot topics of interest that are exponentially growing due to their excellent performance and high throughput [1]. Biosensors have several advantages, such as high throughput, sensitivity, selectivity, real-time detection, ease of use, affordability, speed, and a minimum requirement of reagents [2,3,4]. Generally, biosensors were executed by assimilating the exclusive specificity of genetic responses and the great compassion of corporeal sensors. Thus, there has been an extensive opportunity for solicitations for biological and biochemical sensing methods, as these are pervasive in diverse fields such as food safety, healthcare, clinical, agriculture, environment, and pharmaceutics [5,6,7,8]. A biosensor is an analytical electronic microdevice that produces an electric signal via a bioreceptor and targets molecular interactions. Herein, the primary working principle of a biosensor is to sense the biorecognition incident and translate it into a determinate signal in a procedure called electronic signal processing [9,10]. The essential components of biosensors comprise (i) a biorecognition system or bioreceptor proficient in sensing the bioanalyte, (ii) a transducer that transforms the biorecognition component into a quantifiable signal, and (iii) an electric signal that is processed and incorporated to concoct the signal and to display it on a smartphone in an eco-friendly manner. Usually, biosensors can be categorized based on the bioreceptor event or transducer engaged for several applications. Firstly, in context, the receptors contain the recognition system, such as cells, nucleic acids, proteins, antibodies, peptides, and enzymes. Secondly, concerning the sort of transducer, such as optical (reflection, luminescence, absorption, refraction, fluorescence, etc.), electrochemical (amperometric, potentiometric, conductometric, impedimetric, etc.), and mass-based (piezoelectric) [11,12,13,14,15,16]. Biosensors show a prodigious prospective for evolving analytical tools with limitless applications in diagnosing, averting, and treating pathogens, mostly by identifying the associated specific biomarkers. In addition, these are anticipated to contest the ASSURED criteria recognized by the World Health Organization (WHO); the elaboration is as follows: affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free, and deliverable to end-users [17,18,19,20,21]. Biosensors are commonly used as point-of-care-testing (POCT) devices for biomedical applications that can detect proteins, peptides, oligonucleotides, hormones, metabolites, etc.; these samples can act as biomarkers that are allied with the disease status [22,23].
In recent times, portability has attained a wide range of significance due to its potential applicability to the POCT [24]. The biorecognition of virus status at the receptor has gained wide consideration from several scholars and scientists in the past few decades. Nucleic acids are among the most significant biomarkers and are often studied biomolecules due to their strong connection to gene expression. Even minor DNA sequence variations can lead to distinguished biomedical and clinical insinuations. For example, single nucleotide polymorphisms (SNPs) are alleged to disclose the inherent information of specific predispositions to viruses and the mixed reactions to treatment. Thus, DNA-based biosensors are essential to integrate quantification tactics to identify the existence of common profuse mutations [25,26,27].
Recently, microfluidics has been associated with progressive ideas, which include lab-on-a-chip (LoC) or micro-total-analysis systems (μTAS), that are being established hastily in most research fields due to their assorted prospects and are set to transform the clinical, biochemical, medicinal, biological, healthcare, environmental, food, and agriculture industries [28,29,30]. This technology has emerged in innovative and scientific investigations for numerous biomedical and clinical applications. It deals with science and technology that processes a minuscule volume of reaction samples (<10−18 L) using microchannels ranging from 10 to 100 µm [31,32]. This primarily started its endeavor in the execution of gas chromatographic devices in the mid-1950s; successively, great appliances were being examined to drive and regulate the fluid flow within microfluidic devices [33,34,35,36]. Generally, microfluidic technology relates to fluid mixing, unraveling, relocating, and handling in a small capillary. Haeberle et al. [37] described several microfluidic platforms designed for applications related to microfluidic-based devices. In addition, for delicate identification, these microfluidic-based platforms can be easily coupled and comprehended to brace with diverse biosensor detectors [38,39]. The critical advantage of microfluidic-based biosensors can be recognized in their competence to manage micro/nanoliters of solutions, providing an opportunity to study with a small sample volume for bioanalytical POCT devices [40,41]. Furthermore, by utilizing hydrodynamic services in microchannels with various cross-sections, inertial microfluidic-based systems manage particles, atoms, molecules, and cells passively. These factors have led to the microfluidics field advancing toward large-scale commercial production, playing a significant role in the field’s development, especially in the biomedical area for detecting various biomarkers. Further, a receptor binds the sample, and a transducer transforms the response into an electric signal that electrochemical sensors can determine. Here, the electrode acts as a transducer in electrochemical sensors [42,43,44].
Recently, the biosensor definition was selected by the IUPAC standard; nevertheless, a modern-time appropriate description of the biosensor was earlier expressed by Newman. It refers to a compact analytical device integrated with a bioreceptor component associated with a physiochemical transducer. Clark was the pioneer in the subject of biosensors, publishing a study on the oxygen electrode in 1956. The 1st generation of biosensors were electrocatalytic devices that integrated enzymes with transducers that translated them into electrical signals. In the 2nd generation, affinity biosensors took advantage of discrete biological elements such as receptors, antibodies, and nucleic acids. Further, next generation biosensors are all of these interactions; an affinity interaction, such as DNA–DNA, antibody, antigen, protein, or DNA binding, controls the obligatory between the target analyte and the restrained biomolecule on the transducing element [16,45,46]. The immobilized molecule provides the biosensor system’s specificity. Since then, a sizable number of biosensors with applications in medical diagnosis have been reported in the literature. Actually, this field uses 80% of commercially available biosensor-based devices. Usually, biosensors are employed with several transducing components, such as thermometric, optical, electrochemical, magnetic, and piezoelectric. In the past decades, DNA-based sensing has begun to be used in clinical diagnostics for practical purposes to sense the presence of pathogenic types that cause infections, recognize genetic polymorphisms, and detect fact mutations [47,48,49,50]. Table 1 describes the prominent biosensor companies and target analytes involved in the market.
A biosensor is a logical apparatus that identifies deviations in biological progressions and translates them into electric signals. The term biological process can refer to any biomaterial such as tissues, acids, enzymes, cells, or microorganisms. It is an amalgamation of a biosensing component and a transducer, which transforms the information into electric indicators. Moreover, there will be an amplifier circuit that contains a signal conditioning platform, a controller or processor, and a display section. Figure 1 shows the block diagram of biosensors describing from the sample to the end-term detection.

2. Nucleic Acid-Based Biosensors

An analytical microsystem that includes an oligonucleotide with a known base sequence or composite construction of nucleic acid incorporated into or closely linked to a signal transducer is generally known as a nucleic acid biosensor [66]. DNA-based biosensors can be used to find biochemical or biological species and DNA/RNA templates. The majority of nucleic acid biosensors, also known as genosensors, are based on the extremely specific hybridization of complementary strands of DNA or RNA molecules [67,68]. The transducer is the element that transforms the biorecognition event into a quantifiable signal, while the probe serves as the biorecognition molecule and recognizes the target DNA when it is immobilized on the transducer surface. In nucleic acid biosensors, the hybridization event has been detected using a variety of detection technologies, including label-free ones such as piezoelectric and SPR transduction and others that frequently require labels, such as electrochemical approaches [69,70,71]. Recently, a number of reviews that explain all the critical facets of the transduction phase have appeared in the literature [72,73,74,75]. Figure 2 illustrates the classification of nucleic acid-based biosensors for the detection of nucleic acid.
The capture probe’s design is unquestionably the crucial preanalytical stage because the hybridization response’s specificity relies mainly on the bioreceptor element’s capabilities to seize oligonucleotides. The creation of linear probes uses a variety of commercially accessible firmware that may create detention of oligonucleotides inside highly conserved or hypervariable areas of various genomes following their assembly and alignment. Final tests include employing a basic local alignment search tool (BLAST) to check candidate sequences for homologies, theoretical melting temperature, dimer formation, and length (18–24 nucleotides) [76,77,78,79].
Stringency refers to the experimental factors influencing the hybridization occurrence at the transducer reaction-mixture interface, which typically comprise the composition of the hybridization and post-hybridization coating buffers and the response temperature. The fundamental prerequisite for a functional system when working with complicated sets of probes is the capacity of each probe to hybridize its target orders with high similarity and specificity under the same demanding circumstances. Additionally, some probes that can vary in chemical configuration and conformation have been used to assemble nucleic acid-based sensors [70]. Peptide nucleic acids (PNAs) are neutral N-(2-aminoethyl)-glycine pseudo-peptides that mimic DNA by attaching the nucleobases. PNAs have emerged as particularly intriguing oligonucleotide probe alternatives for the development of electrochemical sensing, primarily due to the vastly differing electrical properties of their molecular backbones [80,81,82,83]. There are many more articles that may be cited in support of this claim, but the authors believe that the works that have tested actual samples should be given more weight than those that have just been considered as a model sequence using less complex synthetic oligonucleotides [84,85].
Because of their extensive utility in screening factors, which is crucial in medical diagnostics, drug delivery, and foodborne pathogens, these biosensors have recently gained relevance. DNA, peptide nucleic acid (PNA), RNA, and aptamers are the numerous kinds of DNA molecules [75,86]. This occurs when the target sequence complements the probe sequence immobilized on the transducer, exhibiting selectivity for non-complementary sequences. Additionally, the biosensor can be categorized according to the biorecognition component: Single-stranded DNA (ssDNA), also referred to as a DNA aptamer, double-stranded DNA, and triple-helical DNA are all examples of DNA-based biosensors. Figure 3 illustrates the hybridization process between the DNA probe and target strands [87,88].

2.1. Riboswitches

Riboswitches are mRNA components that regulate the production of mRNA on the same molecule in which they are encoded by binding to particular metabolite ligands. An expression platform and an aptamer domain make up riboswitches [89]. This switching in the secondary structure of the riboswitch regulates gene expression. Riboswitches are conceptually seen as an advancement of aptamer-based biosensing technology [90].
Small molecules such as ions, metabolites, or uncharged RNA can all be directly bound by riboswitches. A riboswitch in molecular biology is a regulatory section of a messenger RNA molecule that binds a tiny molecule, changing how the mRNA-encoded proteins are produced. Riboswitches can also recognize a variety of compounds with high specificity, including nucleic acids, peptides, carbohydrates, coenzymes, metallic ions, and amino acids [91]. Riboswitches are a promising alternative for biosensing methods since they can distinguish between molecules with identical structures [92]. Adenosylcobalamin concentrations have been effectively used as a biomarker of the metabolic phase in cell cultures, for instance, using a new biosensor that can distinguish between adenosylcobalamin and methylcobalamin.

2.2. Aptamers

These biosensors are a family of ssDNA or ssRNA oligonucleotides used in biochemistry. These are classified as nucleic acid-based biosensor biorecognition elements in biosensing systems. Targets that aptamers can bind to include proteins, medications, cells, and tissues. High selectivity and affinity have been reported for DNA aptamers, which bind to various analytes, including nucleic acids, cells, proteins, viruses, and tiny compounds such as aflatoxin B1, dopamine, cocaine, and metal ions. Additionally, it has been demonstrated that they can differentiate between enantiomers. However, due to the 2’-hydroxyl functional group in RNA aptamers, they often have a higher binding affinity than DNA aptamers to the identical target sequence [93,94].
The binding is the biorecognition event that promotes interaction between the target ligand and the aptamer, a modification in the conformation of the secondary and structures of the aptamer’s tertiary level. Consequently, in these structural modifications, aptamer-based biosensors are in charge of producing a frequently detectable signal. The antigen-antibody and aptamer identification models share certain resemblances regarding the binding pattern mechanism. A significant advantage of aptamers is their three-dimensional structure, which allows for high similarity and binding selectivity [95].
Aptamers are produced with excellent repeatability and inexpensive production costs, can withstand extreme ecological conditions, and can be kept without extra precautions. Finding the precise ssDNA/ssRNA sequences that can attach to the target ligand is the main obstacle in developing aptamer-based biosensors. As a result, libraries of random oligonucleotides and combinatorial approaches are used to select the aptamer sequence. It is a flexible tool since it enables the development of some variants to enhance properties such as the effectiveness and affinity of the aptamer [95].

2.3. Peptide Nucleic Acids (PNA)

The PNAs are synthetic DNA analogues that lack the sugar-phosphate backbone of natural nucleic acids in favor of a neutral peptide-like backbone made up of repeating N-(2-aminoethyl) glycine units. PNAs advantages over native nucleic acid substitute higher stability, including resistance to enzymatic cleavage, improved selectivity, neutral charge, and the ability to be synthesized using standard peptide solid-phase synthesis procedures are all features of DNA and RNA [96,97].
Environmental monitoring, food safety applications, and early disease diagnoses such as cancer have all benefited from the development of RNA or DNA detection biosensors based on PNA. Table 2 summarizes the performance characteristics of various nucleic acid biosensors.
The aforementioned biosensors’ performance traits, which include quick detection, competitive LOD, linear range, and specificity, are generally in line with the ASSURED standards. Most research strongly emphasizes parameter optimization, storage stability assessment, regeneration potential, manufacturing repeatability, and application to composite/genuine matrices [110]. It is essential to highlight the execution of nanomaterials for biosensing devices because they are crucial for cutting-edge biosensor designs and represent a rapidly growing field [111].
Rutten et al. [112] demonstrated a fully integrated microfluidic platform encoded with nanoparticles combined with a microchannel for the simultaneous detection of several diseased-based biomarkers. Hybridization chain reaction (HCR) was investigated as a general strategy to achieve the anticipated sensibility by benefiting from this multiplex platform’s distinctive properties. The sensitivity was dramatically increased by an influence of 104, down to low fM LOD values, compared to a non-amplified reference system (Figure 4A). The efficient but incredibly straightforward isothermal and protein-enzyme-free signal quantification technique achieves LODs for several targets ranging from 33 ± 4 to 151 ± 12 fM. Further, the proposed method can be used directly as a general strategy for the profound and accurate multiplex identification of diverse object compounds.
Anisa Kaur et al. [113] described a nanotweezers (NT)-based sensing approach that works on a single FRET pair and is proficient in sensing several objects. The authors proposed sensors that are sensitive to the low picomolar range (10 pM) and can distinguish between targets with a single base incongruity using nucleic acid mimics of miRNA biomarkers unique to triple-negative breast cancer (TNBC) (Figure 4B). These straightforward hybridization-based sensors have a lot of potential for sensitively detecting various nucleic acid biomarkers.
Wang et al. [114] designed a padlock probe (PP) to sense nucleic acid MTases, which syndicates target identification with the rolling circle amplification (RCA) technique without refinement or using other probes. By introducing MTase to the PP, which served as the enzyme’s substrate, the PP was methylated and protected against the cleavage reactions of HpaII, lambda exonuclease, and ExI, as well as absorption, and the PP started RCA. Thus, after mixing SYBR dye with the RCA, the fluorescent signal could be quickly identified (Figure 4C). This technique’s linear range for M.SssI was 0.5–110 U/mL, and the detection limit was around 0.0404 U/mL. Furthermore, tests for complex biological settings offer opportunities for potential use in complex ecosystems. The developed detection technique can additionally screen medications or inhibitors for MTases.
Coelho et al. [115] reported a digital microfluidics (DMF) technology made explicitly for LAMP of nucleic acid; real-time quantification was accomplished to screen the cancer biomarker c-Myc, which is linked to 45% of all human malignancies. Herein, 90 pg of the target nucleic acid (0.5 ng/L) was successfully amplified in less than an hour after completely modifying the sample and chemicals on this proposed platform. Additionally, using two mixing techniques that provide better fluorescence readouts, low-frequency alternating-current actuation and back-and-forth droplet motion onto the DMF droplets, we investigate the effectiveness of a novel mixing strategy in DMF (Figure 4D). The impacts of fluorophore bleaching are reduced through successive droplet irradiation and on-chip sample splitting via DMF procedures. Finally, compared to benchtop techniques, LAMP processes require 2 µL, a 10-fold volume reduction.
Kokabi et al. [116] proposed a neural network to prophesy nucleic acid quantities united to paramagnetic drops. To this end, a custom-built microfluidic channel was used to sense nucleic acid particles bound to slides by gauging the impedance peak response (IPR) at numerous occurrences. Here, electrical measurements comprise the event and imaginary/real portions of the highest concentration within a miniaturized device as the input of deep-learning simulations to forecast nucleic acid concentration (Figure 5A). Ten distinct deep-learning architectures were explicitly investigated. The proposed regression model’s results show that an R-squared of 96% and a slope of 0.66 are feasible.
Ventimiglia et al. [117] created a silicon lab-on-chip to detect nucleic acids using a hybridization microarray and integrated PCR. A couple of PCR microdevices with a volume capability of 11.2 L and a microarray-hybridization microchamber with a volume of 30 L, which are fluidically united by buried bypass and made up of silicon LoC, were created using bio-MEMS technology (Figure 5B). The nucleic acid microarray probe density was observed, which ranged from 1315 to 2075 probe µm2, and the LOD was 18 target µm−2. The direct identification of the beta-globin gene in human blood proved the principle for silicon microchips.
Iwanaga et al. [118] reported that a meta surface biosensor made up of an all-dielectric meta surface and a microfluidic transparent chip is described as a fast identification method that chains DNA magnification and a precise fluorescence biosensor. The meta surface biosensors recognized amplicons coming from attomolar SARS-CoV-2 nucleic acids, and the magnification was carried out within an hour, according to a series of proof-of-principle experimental results executed in the present scheme (Figure 5C). Furthermore, the dependable infection test criterion of 110 ribonucleic acid copies/150 L, which is a need, is significantly met by this detection competence.
Iwanaga et al. [119] described high-throughput and high-sensitivity meta surface fluorescence biosensors pertinent for DNA templates. The silicon-on-insulator nanorod array used in the all-dielectric meta surface biosensors has durable electromagnetic reverberations that recover fluorescence emission (Figure 5D). The meta surface fluorescence biosensors function well as an uninterrupted detection method.

3. Conclusions and Outlook

Over the past two decades, nucleic acid-based biosensors using microfluidic technology have shown progressive trends in healthcare applications with rapid, robust, reliable, and reusable advantages. Several designs of nucleic acid biosensing devices have been projected to record the reactions of discrete molecular biomarkers comprising lipids, tissues, cells, proteins, nucleic acids, and other molecules engaged in the bioprocesses. Modern nanotechnology, innovative enzyme engineering, exquisite designs based on complex sequence programs, precise base changes, and in vivo/in vitro applications of DNA-based biosensors have all facilitated their use. These days, a wide range of well-established nucleic acid-based biosensing devices have been described and extensively used in several fields, including food safety, ecological screening, disease prognosis, clinical prognosis, etc. Biosensors’ future endeavors can be divided into two categories: making them more specialized or generic; (i) A biosensor with a universal design is more suited for regular usage by regular people, even at home. Folks typically want a conclusion that is straightforward and suitable. The inability to implement a biosensor internationally is due to its lengthy and challenging operation, high cost, and instrument reliance. For instance, when attempting to validate the presence of SARS-COV-2, lateral stream assessment is unquestionably more feasible for a worldwide examination than RT-qPCR. (ii) Most likely, biologists, not chemists, are the ones who want a more consistent biosensor. An ideal biosensor could distribute precise information to track the presence of a bioprocess or realize its workings. Therefore, producing high-performance biosensors in living cells or organisms is critical. In spite of the substantial advantages of miniaturized biosensors in most of the domains, there is still a need for portable devices because of their exploration of space and control of machinery and processes. However, limitations of biosensors depicted in laboratory-based studies and the implementation of cutting-edge technology include design, development, stability, the lack of real-time data analysis amenities such as Bluetooth, internet-of-things (IoT), and specific challenges in cyber-physical-systems (CPS) and machine learning. Furthermore, these devices are still not fully active and reveal unconventional features that may widely apply to point-of-care testing and industrial-scale applications. To overcome the aforementioned challenges, a realization of real-time restraint hinders miniaturized biosensors from practically commercializing these with adaptability and flexibility. Moreover, a straightforward method for signal detection has been made available by the development of improved instrumentation. Therefore, developing advanced biosensors that integrate DNA nanotechnology with attractive equipment will be a promising future direction.

Author Contributions

M.B.K.: conceptualization, data curation, formal analysis, writing—original draft. N.H.A.: supervision, project administration, writing—review and editing, resources. T.M.A.: supervision, writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Dutta, G.; Rainbow, J.; Zupancic, U.; Papamatthaiou, S.; Estrela, P. Microfluidic Devices for Label-Free DNA Detection. Chemosensors 2018, 6, 43. [Google Scholar] [CrossRef] [Green Version]
  2. Holzinger, M.; LeGoff, A.; Cosnier, S. Nanomaterials for biosensing applications: A review. Front. Chem. 2014, 2, 63. [Google Scholar] [CrossRef] [Green Version]
  3. Röhlen, D.L.; Pilas, J.; Dahmen, M.; Keusgen, M.; Selmer, T.; Schöning, M.J. Toward a hybrid biosensor system for analysis of organic and volatile fatty acids in fermentation processes. Front. Chem. 2018, 6, 284. [Google Scholar] [CrossRef]
  4. Kulkarni, M.B.; Ayachit, N.H.; Aminabhavi, T.M. Biosensors and Microfluidic Biosensors: From Fabrication to Application. Biosensors 2022, 12, 543. [Google Scholar] [CrossRef]
  5. Tricoli, A.; Neri, G. Miniaturized bio-and chemical-sensors for point-of-care monitoring of chronic kidney diseases. Sensors 2018, 18, 942. [Google Scholar] [CrossRef] [Green Version]
  6. Kulkarni, M.B.; Ayachit, N.H.; Aminabhavi, T.M. Recent Advancements in Nanobiosensors: Current Trends, Challenges, Applications, and Future Scope. Biosensors 2022, 12, 892. [Google Scholar] [CrossRef]
  7. Kulkarni, M.B.; Upadhyaya, K.; Ayachit, N.H.; Iyer, N. Quantum Dot--Polymer Composites in Light-Emitting Diode Applications. In Quantum Dots and Polymer Nanocomposites; CRC Press: Boca Raton, FL, USA, 2022; pp. 259–279. [Google Scholar]
  8. Umapathi, R.; Rani, G.M.; Kim, E.; Park, S.-Y.; Cho, Y.; Huh, Y.S. Sowing kernels for food safety: Importance of rapid on-site detction of pesticide residues in agricultural foods. Food Front. 2022, 3, 666–676. [Google Scholar] [CrossRef]
  9. Zhao, X.; Li, M.; Liu, Y. Microfluidic-Based Approaches for Foodborne Pathogen Detection. Microorganisms 2019, 7, 381. [Google Scholar] [CrossRef] [Green Version]
  10. Kulkarni, M.B.; Goel, S. Microfluidic devices for synthesizing nanomaterials—A review. Nano Express 2020, 1, 032004. [Google Scholar] [CrossRef]
  11. Yang, Q.; Li, N.; Li, Q.; Chen, S.; Wang, H.L.; Yang, H. Amperometric sarcosine biosensor based on hollow magnetic Pt–Fe3O4@C nanospheres. Anal. Chim. Acta 2019, 1078, 161–167. [Google Scholar] [CrossRef]
  12. Fazli, G.; Bahabadi, S.E.; Adlnasab, L.; Ahmar, H. A glassy carbon electrode modified with a nanocomposite prepared from Pd/Al layered double hydroxide and carboxymethyl cellulose for voltammetric sensing of hydrogen peroxide. Microchim. Acta 2019, 186, 821. [Google Scholar] [CrossRef] [PubMed]
  13. Chin Chwan Chuong, J.J.; Rahman, M.; Ibrahim, N.; Heng, L.Y.; Tan, L.L.; Ahmad, A. Harmful Microalgae Detection: Biosensors versus Some Conventional Methods. Sensors 2022, 22, 3144. [Google Scholar] [CrossRef] [PubMed]
  14. Fan, Y.-J.; Hsu, Y.-C.; Gu, B.-C.; Wu, C.-C. Voltammetric measurement of Escherichia coli concentration through p-APG hydrolysis by endogenous β-galactosidase. Microchem. J. 2020, 154, 104641. [Google Scholar] [CrossRef]
  15. Kulkarni, M.B.; Salve, M.; Goel, S. Miniaturized Thermal Monitoring Module with CO Laser Ablated Microfluidic Device for Electrochemically Validated DNA Amplification. IEEE Trans. Instrum. Meas. 2021, 70, 1–8. [Google Scholar] [CrossRef]
  16. Bhaiyya, M.; Kulkarni, M.B.; Pattnaik, P.K.; Goel, S. Internet of things-enabled photomultiplier tube- and smartphone-based electrochemiluminescence platform to detect choline and dopamine using 3D-printed closed bipolar electrodes. Luminescence 2022, 37, 357–365. [Google Scholar] [CrossRef]
  17. Tamayo, J.; Kosaka, P.M.; Ruz, J.J.; Paulo, Á.S.; Calleja, M. Biosensors based on nanomechanical systems. Chem. Soc. Rev. 2013, 42, 1287–1311. [Google Scholar] [CrossRef] [Green Version]
  18. Sung, W.J.; Bae, Y.H. Glucose oxidase, lactate oxidase, and galactose oxidase enzyme electrode based on polypyrrole with polyanion/PEG/enzyme conjugate dopant. Sens. Actuators B Chem. 2006, 114, 164–169. [Google Scholar] [CrossRef]
  19. Kampeera, J.; Pasakon, P.; Karuwan, C.; Arunrut, N.; Sappat, A.; Sirithammajak, S.; Dechokiattawan, N.; Sumranwanich, T.; Chaivisuthangkura, P.; Ounjai, P.; et al. Point-of-care rapid detection of Vibrio parahaemolyticus in seafood using loop-mediated isothermal amplification and graphene-based screen-printed electrochemical sensor. Biosens. Bioelectron. 2019, 132, 271–278. [Google Scholar] [CrossRef]
  20. Kulkarni, M.B.; Goel, S. A Review on Recent Advancements in Chamber-Based Microfluidic PCR Devices. In Microelectronics and Signal Processing; CRC Press: Boca Raton, FL, USA, 2021; pp. 49–70. [Google Scholar]
  21. Velmurugan, K.; Kulkarni, M.B.; Gupta, I.; Das, R.; Goel, S.; Nirmal, J. Role of Microfluidics in Drug Delivery. In Microfluidics and Multi Organs on Chip; Mohanan, P.V., Ed.; Springer Nature Singapore: Singapore, 2022; pp. 107–133. ISBN 978-981-19-1379-2. [Google Scholar]
  22. Rani, G.M.; Wu, C.-M.; Motora, K.G.; Umapathi, R.; Jose, C.R.M. Acoustic-electric conversion and triboelectric properties of nature-driven CF-CNT based triboelectric nanogenerator for mechanical and sound energy harvesting. Nano Energy 2023, 108, 108211. [Google Scholar] [CrossRef]
  23. Umapathi, R.; Ghoreishian, S.M. Review—Emerging Trends in the Development of Electrochemical Devices for the On-Site Detection of Food Contaminants. ECS Sens. Plus 2022, 1, 044601. [Google Scholar] [CrossRef]
  24. Davidson, E.M.; Croal, B.L. Introduction of an Albumin-to-Creatinine Ratio Point-of-Care Device: Analytic, Clinical, and Cost-effectiveness Aspects. Point Care 2003, 2, 89–95. [Google Scholar] [CrossRef]
  25. Kaprou, G.D.; Papadakis, G.; Papageorgiou, D.P.; Kokkoris, G.; Papadopoulos, V.; Kefala, I.; Gizeli, E.; Tserepi, A. Miniaturized devices for isothermal DNA amplification addressing DNA diagnostics. Microsyst. Technol. 2016, 22, 1529–1534. [Google Scholar] [CrossRef] [Green Version]
  26. Nagai, H.; Fuchiwaki, Y. Portable microfluidic system for rapid genetic testing. Electron. Commun. Jpn. 2015, 98, 1–6. [Google Scholar] [CrossRef]
  27. Kumar, K.; Kim, E.; Alhammadi, M.; Reddicherla, U.; Aliya, S.; Tiwari, J.N.; Park, H.S.; Choi, J.H.; Son, C.Y.; Vilian, A.T.E.; et al. Recent advances in microfluidic approaches for the isolation and detection of exosomes. TrAC Trends Anal. Chem. 2023, 159, 116912. [Google Scholar] [CrossRef]
  28. Kulkarni, M.B.; Goel, S. Recent advancements in integrated microthermofluidic systems for biochemical and biomedical applications—A review. Sens. Actuators A Phys. 2022, 341, 113590. [Google Scholar] [CrossRef]
  29. Kulkarni, M.B.; Goel, S. Advances in continuous-flow based microfluidic PCR devices—A review. Eng. Res. Express 2020, 2, 042001. [Google Scholar] [CrossRef]
  30. Puneeth, S.B.; Kulkarni, M.B.; Goel, S. Microfluidic viscometers for biochemical and biomedical applications: A review. Eng. Res. Express 2021, 3, 022003. [Google Scholar] [CrossRef]
  31. Li, X.; Wu, W.; Manz, A. Thermal gradient for fluorometric optimization of droplet PCR in virtual reaction chambers. Microchim. Acta 2017, 184, 3433–3439. [Google Scholar] [CrossRef]
  32. Aliya, S.; Lee, H.; Alhammadi, M.; Umapathi, R.; Huh, Y.S. An Overview on Single-Cell Technology for Hepatocellular Carcinoma Diagnosis. Int. J. Mol. Sci. 2022, 23, 1402. [Google Scholar] [CrossRef] [PubMed]
  33. Naji, O.P.; Bessoth, F.G.; Manz, A. Novel Injection Methods for Miniaturised Gas Chromatography. In Micro Total Analysis Systems 2001, Proceedings of the µTAS 2001 Symposium, Monterey, CA, USA, 21–25 October 2001; Springer Netherlands: Dordrecht, The Netherlands, 2001; pp. 655–657. [Google Scholar] [CrossRef]
  34. Kulkarni, M.B.; Goyal, S.; Dhar, A.; Sriram, D.; Goel, S. Miniaturized and IoT Enabled Continuous-Flow-Based Microfluidic PCR Device for DNA Amplification. IEEE Trans. Nanobiosci. 2022, 21, 97–104. [Google Scholar] [CrossRef]
  35. Jiang, Y.; Manz, A.; Wu, W. Fully automatic integrated continuous-flow digital PCR device for absolute DNA quantification. Anal. Chim. Acta 2020, 1125, 50–56. [Google Scholar] [CrossRef]
  36. Pathak, A.K.; Rahman, B.M.A.; Singh, V.K.; Kumari, S. Sensitivity enhancement of a concave shaped optical fiber refractive index sensor covered with multiple au nanowires. Sensors 2019, 19, 4210. [Google Scholar] [CrossRef] [Green Version]
  37. Haeberle, S.; Zengerle, R. Microfluidic platforms for lab-on-a-chip applications. Lab Chip 2007, 7, 1094–1110. [Google Scholar] [CrossRef]
  38. Kukkar, D.; Zhang, D.; Jeon, B.H.; Kim, K.-H. Recent advances in wearable biosensors for non-invasive monitoring of specific metabolites and electrolytes associated with chronic kidney disease: Performance evaluation and future challenges. TrAC Trends Anal. Chem. 2022, 150, 116570. [Google Scholar] [CrossRef]
  39. Mohan, J.M.; Amreen, K.; Kulkarni, M.B.; Javed, A.; Dubey, S.K.; Goel, S. Optimized Ink Jetted Paper Device for Electroanalytical Detection of Picric Acid. Colloids Surfaces B Biointerfaces 2021, 208, 112056. [Google Scholar] [CrossRef]
  40. Yao, L.; Wang, L.; Huang, F.; Cai, G.; Xi, X.; Lin, J. A microfluidic impedance biosensor based on immunomagnetic separation and urease catalysis for continuous-flow detection of E. coli O157:H7. Sens. Actuators B Chem. 2018, 259, 1013–1021. [Google Scholar] [CrossRef]
  41. Xu, M.; Wang, R.; Li, Y. An electrochemical biosensor for rapid detection of: E. coli O157:H7 with highly efficient bi-functional glucose oxidase-polydopamine nanocomposites and Prussian blue modified screen-printed interdigitated electrodes. Analyst 2016, 141, 5441–5449. [Google Scholar] [CrossRef] [Green Version]
  42. Zhu, T.; Wang, X.; Chang, W.; Zhang, Y.; Maruyama, T.; Luo, L.; Zhao, X. Green fabrication of Cu/rGO decorated SWCNT buckypaper as a flexible electrode for glucose detection. Mater. Sci. Eng. C 2021, 120, 111757. [Google Scholar] [CrossRef] [PubMed]
  43. Lee, M.; Zine, N.; Baraket, A.; Zabala, M.; Campabadal, F.; Caruso, R.; Trivella, M.G.; Jaffrezic-Renault, N.; Errachid, A. A novel biosensor based on hafnium oxide: Application for early stage detection of human interleukin-10. Sens. Actuators B Chem. 2012, 175, 201–207. [Google Scholar] [CrossRef]
  44. Kulkarni, M.B.; Velmurugan, K.; Prasanth, E.; Amreen, K.; Nirmal, J.; Goel, S. Smartphone enabled miniaturized temperature controller platform to synthesize nio/cuo nanoparticles for electrochemical sensing and nanomicelles for ocular drug delivery applications. Biomed. Microdevices 2021, 23, 31. [Google Scholar] [CrossRef] [PubMed]
  45. Kulkarni, M.B.; Goel, S. Miniaturized DNA amplification platform with soft-lithographically fabricated continuous-flow PCR microfluidic device on a portable temperature controller. Microfluid. Nanofluid. 2021, 25, 69. [Google Scholar] [CrossRef]
  46. Kulkarni, M.B.; Jayapiriya, U.S.; Amreen, K.; Goel, S. Portable Thermal Management Platform for Synthesis of ZnO Nanoparticle in a Microfluidic Device: Validated for Electrochemical Sensing and Glucose Fuel Cell Applications. IEEE Trans. Electron. Devices 2021, 68, 4070–4076. [Google Scholar] [CrossRef]
  47. Kulkarni, M.B.; Channappa Bhyri, D.; Vanjerkhede, K. Brain Tumor Detection using Random Walk Solver Based Segmentation from MRI. Microsc. Res. Tech. 2018, 20, 1–8. [Google Scholar]
  48. Kulkarni, M.B. Automated and Integrated Microthermofluidic Platforms for DNA Amplification and Nanomaterial Synthesis. Ph.D. Thesis, BITS-Pilani, Hyderabad Campus, Secunderabad, India, 2022. [Google Scholar]
  49. Justino, C.I.L.; Duarte, A.C.; Rocha-Santos, T.A.P. Critical overview on the application of sensors and biosensors for clinical analysis. TrAC-Trends Anal. Chem. 2016, 85, 36–60. [Google Scholar] [CrossRef]
  50. Yerlikaya, S.; Broger, T.; MacLean, E.; Pai, M.; Denkinger, C.M. A tuberculosis biomarker database: The key to novel TB diagnostics. Int. J. Infect. Dis. 2017, 56, 253–257. [Google Scholar] [CrossRef] [Green Version]
  51. Lorenz, H.M. Technology evaluation: Adalimumab, Abbott laboratories. Curr. Opin. Mol. Ther. 2002, 4, 185–190. [Google Scholar] [PubMed]
  52. McCall, M.N.; Murakami, P.N.; Lukk, M.; Huber, W.; Irizarry, R.A. Assessing affymetrix GeneChip microarray quality. BMC Bioinform. 2011, 12, 137. [Google Scholar] [CrossRef] [Green Version]
  53. Ondov, B.D.; Varadarajan, A.; Passalacqua, K.D.; Bergman, N.H. Efficient mapping of Applied Biosystems SOLiD sequence data to a reference genome for functional genomic applications. Bioinformatics 2008, 24, 2776–2777. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Nakamura, T.; Nakashima, C.; Komiya, K.; Kitera, K.; Hirai, M.; Kimura, S.; Aragane, N. Mechanisms of acquired resistance to afatinib clarified with liquid biopsy. PLoS ONE 2018, 13, e0209384. [Google Scholar] [CrossRef] [PubMed]
  55. Rumley, A. Urine dipstick testing: Comparison of results obtained by visual reading and with the Bayer CLINITEK 50. Ann. Clin. Biochem. 2000, 37, 220–221. [Google Scholar] [CrossRef]
  56. Holmes, K.L.; Otten, G.; Yokoyama, W.M. Flow Cytometry Analysis Using the Becton Dickinson FACS Calibur. Curr. Protoc. Immunol. 2002, 49, 5.4.1–5.4.22. [Google Scholar] [CrossRef]
  57. Jason-Moller, L.; Murphy, M.; Bruno, J. Overview of Biacore Systems and Their Applications. Curr. Protoc. Protein Sci. 2006, 45, 19.13.1–19.13.14. [Google Scholar] [CrossRef]
  58. Bose, A.; Lategan, C.A.; Smith, P.J.; Gupta, J.K. Studies on in vitro antiplasmodial activity of cleome rutidosperma. Acta Polanica Pharm. Drug. Res. 2010, 67, 315–318. [Google Scholar]
  59. Fogh-Andersen, N.; D’Orazio, P. Proposal for standardizing direct-reading biosensors for blood glucose. Clin. Chem. 1998, 44, 655–659. [Google Scholar] [CrossRef] [Green Version]
  60. Tomlinson, E.; Fu, L.; John, L.; Hultgren, B.; Huang, X.; Renz, M.; Stephan, J.P.; Tsai, S.P.; Powell-Braxton, L.; French, D.; et al. Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity. Endocrinology 2002, 143, 1741–1747. [Google Scholar] [CrossRef]
  61. Jeong, H.; Kim, D.; Wang, G.; Park, S.; Lee, H.; Cho, K.; Hwang, W.-T.; Yoon, M.-H.; Jang, Y.H.; Song, H.; et al. Redox-Induced Asymmetric Electrical Characteristics of Ferrocene-Alkanethiolate Molecular Devices on Rigid and Flexible Substrates. Adv. Funct. Mater. 2014, 24, 2472–2480. [Google Scholar] [CrossRef]
  62. Sassolas, A.; Leca-Bouvier, B.D.; Blum, L.J. DNA Biosensors and Microarrays. Chem. Rev. 2008, 108, 109–139. [Google Scholar] [CrossRef]
  63. Lee-Lewandrowski, E.; Januzzi, J.L.; Green, S.M.; Tannous, B.; Wu, A.H.B.; Smith, A.; Wong, A.; Murakami, M.M.; Kaczmarek, J.; Apple, F.S.; et al. Multi-center validation of the Response Biomedical Corporation RAMP® NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys® proBNP assay. Clin. Chim. Acta 2007, 386, 20–24. [Google Scholar] [CrossRef]
  64. Conjeevaram, A.; Anupama, Y.J.; Vincent, L.; Sastry, N.B.; Siddini, V.; Revanasiddappa, M.; Srinivasa, S.; Thimmegeowda, A.B.; Kulkarni, M.J.; Patil, V.S. Clinico-Epidemiological Profile of Dialysis Services in Karnataka, India–A Multicentric Exploratory Study. Indian J. Nephrol. 2022, 32, 223–232. [Google Scholar] [CrossRef]
  65. Churakova, E.; Peri, K.; Vis, J.S.; Smith, D.W.; Beam, J.M.; Vijverberg, M.P.; Stor, M.C.; Winter, R.T. Accurate analysis of residual lactose in low-lactose milk: Comparing a variety of analytical techniques. Int. Dairy J. 2019, 96, 126–131. [Google Scholar] [CrossRef]
  66. Xu, L.; Liang, W.; Wen, Y.; Wang, L.; Yang, X.; Ren, S.; Jia, N.; Zuo, X.; Liu, G. An ultrasensitive electrochemical biosensor for the detection of mecA gene in methicillin-resistant Staphylococcus aureus. Biosens. Bioelectron. 2018, 99, 424–430. [Google Scholar] [CrossRef] [PubMed]
  67. Li, Y.; Zhang, C.; Xing, D. Fast identification of foodborne pathogenic viruses using continuous-flow reverse transcription-PCR with fluorescence detection. Microfluid. Nanofluid. 2011, 10, 367–380. [Google Scholar] [CrossRef]
  68. Obeid, P.J.; Christopoulos, T.K.; Crabtree, H.J.; Backhouse, C.J. Microfabricated device for DNA and RNA amplification by continuous-flow polymerase chain reaction and reverse transcription-polymerase chain reaction with cycle number selection. Anal. Chem. 2003, 75, 288–295. [Google Scholar] [CrossRef]
  69. Venkateswara Raju, C.; Hwan Cho, C.; Mohana Rani, G.; Manju, V.; Umapathi, R.; Suk Huh, Y.; Pil Park, J. Emerging insights into the use of carbon-based nanomaterials for the electrochemical detection of heavy metal ions. Coord. Chem. Rev. 2023, 476, 214920. [Google Scholar] [CrossRef]
  70. Kulkarni, M.B.; Ayachit, N.H.; Aminabhavi, T.M. Recent Advances in Microfluidics-Based Electrochemical Sensors for Foodborne Pathogen Detection. Biosensors 2023, 13, 246. [Google Scholar] [CrossRef] [PubMed]
  71. Kulkarni, M.B.; Yashas; Enaganti, P.K.; Amreen, K.; Goel, S. Internet of Things enabled portable thermal management system with microfluidic platform to synthesize MnO2 nanoparticles for electrochemical sensing. Nanotechnology 2020, 31, 425504. [Google Scholar] [CrossRef]
  72. Goto, M.; Honda, E.; Ogura, A.; Nomoto, A.; Hanaki, K.I. Colorimetric detection of loop-mediated isothermal amplification reaction by using hydroxy naphthol blue. Biotechniques 2009, 46, 167–172. [Google Scholar] [CrossRef]
  73. Fernández-Carballo, B.L.; McBeth, C.; McGuiness, I.; Kalashnikov, M.; Baum, C.; Borrós, S.; Sharon, A.; Sauer-Budge, A.F. Continuous-flow, microfluidic, qRT-PCR system for RNA virus detection. Anal. Bioanal. Chem. 2018, 410, 33–43. [Google Scholar] [CrossRef]
  74. Cui, F.; Xu, Y.; Wang, R.; Liu, H.; Chen, L.; Zhang, Q.; Mu, X. Label-free impedimetric glycan biosensor for quantitative evaluation interactions between pathogenic bacteria and mannose. Biosens. Bioelectron. 2018, 103, 94–98. [Google Scholar] [CrossRef]
  75. Kaur, H.; Shorie, M.; Sharma, M.; Ganguli, A.K.; Sabherwal, P. Bridged Rebar Graphene functionalized aptasensor for pathogenic E. coli O78:K80:H11 detection. Biosens. Bioelectron. 2017, 98, 486–493. [Google Scholar] [CrossRef]
  76. Sharma, E.; Rathi, R.; Misharwal, J.; Sinhmar, B.; Kumari, S.; Dalal, J.; Kumar, A. Evolution in Lithography Techniques: Microlithography to Nanolithography. Nanomaterials 2022, 12, 2754. [Google Scholar] [CrossRef] [PubMed]
  77. Bilan, R.; Fleury, F.; Nabiev, I.; Sukhanova, A. Quantum dot surface chemistry and functionalization for cell targeting and imaging. Bioconjug. Chem. 2015, 26, 609–624. [Google Scholar] [CrossRef]
  78. Tian, H.; Sun, Y.; Liu, C.; Duan, X.; Tang, W.; Li, Z. Precise quantitation of MicroRNA in a single cell with droplet digital PCR based on ligation reaction. Anal. Chem. 2016, 88, 11384–11389. [Google Scholar] [CrossRef] [PubMed]
  79. Dutta, P.; Lu, Y.-J.; Hsieh, H.-Y.; Lee, T.-Y.; Lee, Y.-T.; Cheng, C.-M.; Fan, Y.-J. Detection of Candida albicans Using a Manufactured Electrochemical Sensor. Micromachines 2021, 12, 166. [Google Scholar] [CrossRef]
  80. Chadha, U.; Bhardwaj, P.; Agarwal, R.; Rawat, P.; Agarwal, R.; Gupta, I.; Panjwani, M.; Singh, S.; Ahuja, C.; Selvaraj, S.K.; et al. Recent progress and growth in biosensors technology: A critical review. J. Ind. Eng. Chem. 2022, 109, 21–51. [Google Scholar] [CrossRef]
  81. Martin, C.R.; Kohli, P. The emerging field of nanotube biotechnology. Nat. Rev. Drug Discov. 2003, 2, 29–37. [Google Scholar] [CrossRef] [PubMed]
  82. Datta, D.; Panchal, D.S.; Venuganti, V.V.K. Transdermal delivery of vancomycin hydrochloride: Influence of chemical and physical permeation enhancers. Int. J. Pharm. 2021, 602, 120663. [Google Scholar] [CrossRef] [PubMed]
  83. Bell, J. The polymerase chain reaction. Immunol. Today 1989, 10, 351–355. [Google Scholar] [CrossRef]
  84. Hertneky, B.; Eger, J.; Bailly, M.; Christen, J.B. Mobile and Efficient Temperature and Humidity Control Chamber for Point-of-Care Diagnostics. In Proceedings of the 2019 IEEE Healthcare Innovations and Point of Care Technologies, (HI-POCT), Bethesda, MD, USA, 20–22 November 2019; pp. 159–162. [Google Scholar] [CrossRef]
  85. Mehrotra, P. Biosensors and their applications—A review. J. Oral Biol. Craniofacial Res. 2016, 6, 153–159. [Google Scholar] [CrossRef] [Green Version]
  86. Bhalla, N.; Jolly, P.; Formisano, N.; Estrela, P. Introduction to biosensors. Essays Biochem. 2016, 60, 1–8. [Google Scholar] [CrossRef] [Green Version]
  87. Diculescu, V.C.; Chiorcea-Paquim, A.M.; Oliveira-Brett, A.M. Applications of a DNA-electrochemical biosensor. TrAC-Trends Anal. Chem. 2016, 79, 23–36. [Google Scholar] [CrossRef]
  88. Chen, G.; Chen, R.; Ding, S.; Li, M.; Wang, J.; Zou, J.; Du, F.; Dong, J.; Cui, X.; Huang, X.; et al. Recombinase assisted loop-mediated isothermal DNA amplification. Analyst 2020, 145, 440–444. [Google Scholar] [CrossRef]
  89. Teng, J.; Ye, Y.; Yao, L.; Yan, C.; Cheng, K.; Xue, F.; Pan, D.; Li, B.; Chen, W. Rolling circle amplification based amperometric aptamer/immuno hybrid biosensor for ultrasensitive detection of Vibrio parahaemolyticus. Microchim. Acta 2017, 184, 3477–3485. [Google Scholar] [CrossRef]
  90. Jiang, X.; Shao, N.; Jing, W.; Tao, S.; Liu, S.; Sui, G. Microfluidic chip integrating high throughput continuous-flow PCR and DNA hybridization for bacteria analysis. Talanta 2014, 122, 246–250. [Google Scholar] [CrossRef] [PubMed]
  91. Garst, A.D.; Edwards, A.L.; Batey, R.T. Riboswitches: Structures and mechanisms. Cold Spring Harb. Perspect. Biol. 2011, 3, a003533. [Google Scholar] [CrossRef]
  92. Roth, A.; Breaker, R.R. The structural and functional diversity of metabolite-binding riboswitches. Annu. Rev. Biochem. 2009, 78, 305–334. [Google Scholar] [CrossRef] [Green Version]
  93. Liss, M.; Petersen, B.; Wolf, H.; Prohaska, E. An aptamer-based quartz crystal protein biosensor. Anal. Chem. 2002, 74, 4488–4495. [Google Scholar] [CrossRef]
  94. Mishra, A.; Pilloton, R.; Jain, S.; Roy, S.; Khanuja, M.; Mathur, A.; Narang, J. Paper-Based Electrodes Conjugated with Tungsten Disulfide Nanostructure and Aptamer for Impedimetric Detection of Listeria monocytogenes. Biosensors 2022, 12, 88. [Google Scholar] [CrossRef]
  95. Cai, R.; Zhang, Z.; Chen, H.; Tian, Y.; Zhou, N. A versatile signal-on electrochemical biosensor for Staphylococcus aureus based on triple-helix molecular switch. Sens. Actuators B Chem. 2021, 326, 128842. [Google Scholar] [CrossRef]
  96. Dave, V.; Tak, K.; Sohgaura, A.; Gupta, A.; Sadhu, V.; Reddy, K.R. Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications. J. Microbiol. Methods 2019, 160, 130–142. [Google Scholar] [CrossRef]
  97. Malvano, F.; Pilloton, R.; Albanese, D. A novel impedimetric biosensor based on the antimicrobial activity of the peptide nisin for the detection of Salmonella spp. Food Chem. 2020, 325, 126868. [Google Scholar] [CrossRef] [PubMed]
  98. Alava, T.; Berthet-Duroure, N.; Ayela, C.; Trévisiol, E.; Pugnière, M.; Morel, Y.; Rameil, P.; Nicu, L. Parallel acoustic detection of biological warfare agents surrogates by means of piezoelectric immunochips. Sens. Actuators B Chem. 2009, 138, 532–538. [Google Scholar] [CrossRef]
  99. Muthamma, K.; Sunil, D.; Shetty, P. Carbon dots as emerging luminophores in security inks for anti-counterfeit applications—An up-to-date review. Appl. Mater. Today 2021, 23, 101050. [Google Scholar] [CrossRef]
  100. Roushani, M.; Rahmati, Z.; Golchin, M.; Lotfi, Z.; Nemati, M. Electrochemical immunosensor for determination of Staphylococcus aureus bacteria by IgY immobilized on glassy carbon electrode with electrodeposited gold nanoparticles. Microchim. Acta 2020, 187, 567. [Google Scholar] [CrossRef] [PubMed]
  101. Rewatkar, P.; Bandapati, M.; Goel, S. Miniaturized additively manufactured co-laminar microfluidic glucose biofuel cell with optimized grade pencil bioelectrodes. Int. J. Hydrogen Energy 2019, 44, 31434–31444. [Google Scholar] [CrossRef]
  102. Simonian, A.L.; Grimsley, J.K.; Flounders, A.W.; Schoeniger, J.S.; Cheng, T.C.; DeFrank, J.J.; Wild, J.R. Enzyme-based biosensor for the direct detection of fluorine-containing organophosphates. Anal. Chim. Acta 2001, 442, 15–23. [Google Scholar] [CrossRef]
  103. Roy, A.; Ray, A.; Saha, S.; Ghosh, M.; Das, T.; Satpati, B.; Nandi, M.; Das, S. NiO-CNT composite for high performance supercapacitor electrode and oxygen evolution reaction. Electrochim. Acta 2018, 283, 327–337. [Google Scholar] [CrossRef]
  104. Knob, R.; Hanson, R.L.; Tateoka, O.B.; Wood, R.L.; Guerrero-Arguero, I.; Robison, R.A.; Pitt, W.G.; Woolley, A.T. Sequence-specific sepsis-related DNA capture and fluorescent labeling in monoliths prepared by single-step photopolymerization in microfluidic devices. J. Chromatogr. A 2018, 1562, 12–18. [Google Scholar] [CrossRef] [PubMed]
  105. Rhouati, A.; Hayat, A.; Hernandez, D.B.; Meraihi, Z.; Munoz, R.; Marty, J.L. Development of an automated flow-based electrochemical aptasensor for on-line detection of Ochratoxin A. Sens. Actuators B Chem. 2013, 176, 1160–1166. [Google Scholar] [CrossRef]
  106. Ali, S.; Hassan, A.; Hassan, G.; Eun, C.H.; Bae, J.; Lee, C.H.; Kim, I.J. Disposable all-printed electronic biosensor for instantaneous detection and classification of pathogens. Sci. Rep. 2018, 8, 5920. [Google Scholar] [CrossRef] [Green Version]
  107. Gou, T.; Hu, J.; Wu, W.; Ding, X.; Zhou, S.; Fang, W.; Mu, Y. Smartphone-based mobile digital PCR device for DNA quantitative analysis with high accuracy. Biosens. Bioelectron. 2018, 120, 144–152. [Google Scholar] [CrossRef] [PubMed]
  108. Chen, P.C.; Duong, L.H. Novel solvent bonding method for thermoplastic microfluidic chips. Sens. Actuators B Chem. 2016, 237, 556–562. [Google Scholar] [CrossRef]
  109. Wei, Y.P.; Zhang, Y.W.; Mao, C.J. A silver nanoparticle-assisted signal amplification electrochemiluminescence biosensor for highly sensitive detection of mucin 1. J. Mater. Chem. B 2020, 8, 2471–2475. [Google Scholar] [CrossRef] [PubMed]
  110. Lee, J.; Jang, J.; Choi, B.; Yoon, J.; Kim, J.Y.; Choi, Y.K.; Myong Kim, D.; Hwan Kim, D.; Choi, S.J. A Highly Responsive Silicon Nanowire/Amplifier MOSFET Hybrid Biosensor. Sci. Rep. 2015, 5, 12286. [Google Scholar] [CrossRef] [Green Version]
  111. Qiu, X.; Mauk, M.G. An integrated, cellulose membrane-based PCR chamber. Microsyst. Technol. 2015, 21, 841–850. [Google Scholar] [CrossRef]
  112. Rutten, I.; Daems, D.; Leirs, K. Highly Sensitive Multiplex Detection of Molecular Biomarkers Using Hybridization Chain Reaction in an Encoded Particle Microfluidic Platform. Biosensors 2023, 13, 100. [Google Scholar] [CrossRef]
  113. Kaur, A.; Mahmoud, R.; Megalathan, A.; Pettit, S.; Dhakal, S. Multiplexed smFRET Nucleic Acid Sensing Using DNA Nanotweezers. Biosensors 2023, 13, 119. [Google Scholar] [CrossRef]
  114. Wang, Y.; Han, Y.; Zhou, F.; Fan, T.; Liu, F. Simple Detection of DNA Methyltransferase with an Integrated Padlock Probe. Biosensors 2022, 12, 569. [Google Scholar] [CrossRef]
  115. Coelho, B.J.; Veigas, B.; Bettencourt, L.; Águas, H.; Fortunato, E.; Martins, R.; Baptista, P.V.; Igreja, R. Digital Microfluidics-Powered Real-Time Monitoring of Isothermal DNA Amplification of Cancer Biomarker. Biosensors 2022, 12, 201. [Google Scholar] [CrossRef]
  116. Kokabi, M.; Sui, J.; Gandotra, N.; Pournadali Khamseh, A.; Scharfe, C.; Javanmard, M. Nucleic Acid Quantification by Multi-Frequency Impedance Cytometry and Machine Learning. Biosensors 2023, 13, 316. [Google Scholar] [CrossRef]
  117. Ventimiglia, G.; Pesaturo, M.; Malcolm, A.; Petralia, S. A Miniaturized Silicon Lab-on-Chip for Integrated PCR and Hybridization Microarray for High Multiplexing Nucleic Acids Analysis. Biosensors 2022, 12, 563. [Google Scholar] [CrossRef] [PubMed]
  118. Iwanaga, M. Rapid Detection of Attomolar SARS-CoV-2 Nucleic Acids in All-Dielectric Metasurface Biosensors. Biosensors 2022, 12, 987. [Google Scholar] [CrossRef] [PubMed]
  119. Iwanaga, M. High-Sensitivity High-Throughput Detection of Nucleic Acid Targets on Metasurface Fluorescence Biosensors. Biosensors 2021, 11, 33. [Google Scholar] [CrossRef] [PubMed]
Biosensors 13 00412 g001 550
Figure 1. Block diagram representation of biosensors: from analyte to detection.
Figure 1. Block diagram representation of biosensors: from analyte to detection.
Biosensors 13 00412 g001
Biosensors 13 00412 g002 550
Figure 2. Classification of nucleic acid-based biosensors for detection of nucleic acid.
Figure 2. Classification of nucleic acid-based biosensors for detection of nucleic acid.
Biosensors 13 00412 g002
Biosensors 13 00412 g003 550
Figure 3. The bioreceptor component in nucleic acid-based biosensors for detecting nucleic acids resembles the hybridization process between DNA probe and target strands.
Figure 3. The bioreceptor component in nucleic acid-based biosensors for detecting nucleic acids resembles the hybridization process between DNA probe and target strands.
Biosensors 13 00412 g003
Biosensors 13 00412 g004 550
Figure 4. (A) Schematic representation of the components, including digitally barcoded nanoparticles, microfluidic cartridge, and an integrated instrument for the detection of molecular biomarkers [112] (B) Working principle of the nucleic acid-based nanotweezer sensor [113] (C) MTase activity uncovering by padlock probe with RCA technique [114] (D) Multi-view of the DMF device and accumulation [115].
Figure 4. (A) Schematic representation of the components, including digitally barcoded nanoparticles, microfluidic cartridge, and an integrated instrument for the detection of molecular biomarkers [112] (B) Working principle of the nucleic acid-based nanotweezer sensor [113] (C) MTase activity uncovering by padlock probe with RCA technique [114] (D) Multi-view of the DMF device and accumulation [115].
Biosensors 13 00412 g004
Biosensors 13 00412 g005 550
Figure 5. (A) Overview of the process and microscopic cross section of channel and electrodes [116] (B) Schematic of the LoC developed by STMicroelectronics [117] (C) Schematic of meta surface biosensors [118] (D) Schematic of dielectric meta surface structure and the whole view of meta surface substrate [119].
Figure 5. (A) Overview of the process and microscopic cross section of channel and electrodes [116] (B) Schematic of the LoC developed by STMicroelectronics [117] (C) Schematic of meta surface biosensors [118] (D) Schematic of dielectric meta surface structure and the whole view of meta surface substrate [119].
Biosensors 13 00412 g005
Table
Table 1. Prominent biosensor companies and targets involved in the market.
Table 1. Prominent biosensor companies and targets involved in the market.
CompanyFoundation YearTargetsCost (~$)Ref.
Abbott1888Glucose biosensor48.85[51]
Affymetrix1992Pharmaceutical research-[52]
Applied Biosystems1981Affinity chip69.95[53]
ARKRAY, Inc.1960Creatinine biosensor21.25[54]
Bayer Diagnostics1958Glucose biosensor42.78[55]
Becton Dickinson1897Glucose biosensor45.37[56]
Biacore1984Affinity sensors for medical research56.32[57]
Cleome Innovations2021Medical POCT devices18.26[58]
Eppendorf Inc.1989Medical diagnostics19.37[59]
LifeScan1981Lactate14.31[60]
Molecular devices1983Pharmaceutical-[61]
Nanogen1993Glucose, urea, creatinine, and lactate biosensors20.35[62]
Roche Diagnostics1896Glucose biosensors38.21[63]
Renalyx Healthcare Systems2013Creatinine and albumin sensors19.21[64]
YSI Inc.1948Lactate13.24[65]
Table
Table 2. Summary of performance characteristics for the various nucleic acid biosensors.
Table 2. Summary of performance characteristics for the various nucleic acid biosensors.
Biorecognition ComponentBioanalyteTransducerLimit of DetectionApplicationRef.
DNANuclei acidsQCM450 fMEco-friendly biointerfaces[98]
ssDNARNAFluorescence 180 pMEarly disease diagnosis[99]
PNAssDNAGCE2.58 pMNS[100]
PNAmiRNA-492 suggested biomarker for PDCAGraphite oxide with gold NPs8 nMEarly identification of PDCA[101]
PNARNAG-FET0.2 aMNS[102]
AptamerPDGFCNT-Atherosclerosis, fibrosis, malevolent viruses[103]
ssDNASynthetic DNA of E. faecalisElectrode with Gold NPs3.4 amol L−1Early detection of pathogens in food[104]
AptamerSynthetic DNA of Group B StreptococciGold NPs0.5 fMEarly detection of bacteria[105]
Arched probeaptamer, Hairpin probe-1 and 2Salmonella typhimuriumLuminescence1.6 CFU mL−1Adulteration in milk[106]
3D-Printed PMMA chipSalmonella enteritis and Staphylococcus aureusLuminescence5 CFU mL−1Microfluidic-based biosensor for identification of virulent [107]
Polyacrylamidehydrogel:aptamer strandsMicrocystin-LRColorimetric3.5 ng L−1Detection of fresh fish[108]
Aptamer hairpinSalmonella typhimuriumGold electrode0.98 fMGenomic DNA from clinical anal/vaginal samples[109]
ssDNA = single-stranded deoxyribonucleic acid; PDCA = pancreatic ductal adenocarcinoma; PNA = peptide nucleic acid; RNA = ribonucleic acid; NPs = nanoparticles; GCE = glassy carbon electrode; QCM = quartz crystal microbalance; G-FET = graphene field effect transistors; CNT = carbon nanotube; PDGF = platelet-derived growth factor; NS: not specified.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kulkarni, M.B.; Ayachit, N.H.; Aminabhavi, T.M. A Short Review on Miniaturized Biosensors for the Detection of Nucleic Acid Biomarkers. Biosensors 2023, 13, 412. https://doi.org/10.3390/bios13030412

AMA Style

Kulkarni MB, Ayachit NH, Aminabhavi TM. A Short Review on Miniaturized Biosensors for the Detection of Nucleic Acid Biomarkers. Biosensors. 2023; 13(3):412. https://doi.org/10.3390/bios13030412

Chicago/Turabian Style

Kulkarni, Madhusudan B., Narasimha H. Ayachit, and Tejraj M. Aminabhavi. 2023. "A Short Review on Miniaturized Biosensors for the Detection of Nucleic Acid Biomarkers" Biosensors 13, no. 3: 412. https://doi.org/10.3390/bios13030412

APA Style

Kulkarni, M. B., Ayachit, N. H., & Aminabhavi, T. M. (2023). A Short Review on Miniaturized Biosensors for the Detection of Nucleic Acid Biomarkers. Biosensors, 13(3), 412. https://doi.org/10.3390/bios13030412

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop